With more and more molecular glues, induced proximity, and targeted protein degradation approaches crowding the clinic, a landscape view of this emerging field has critical implications in therapeutic areas like cancer, autoimmune, and neurodegenerative diseases. Learn more in our latest white paper with unique CAS insights, and a view to future opportunities.
Targeted protein degradation and induced proximity: Molecular glues landscape in drug discovery
Targeted protein degradation and induced proximity: Molecular glues landscape in drug discovery
Download the CAS Insights Report